eNeura's SAVI Dual sTMS Neuromodulation Treatment Integrated into Federal Supply Schedule
eNeura Inc. has marked an impressive milestone with the inclusion of its flagship product, the SAVI Dual sTMS Neuromodulation treatment, into a key federal contract. This opens new avenues for veterans, active-duty military personnel, and various federal healthcare beneficiaries who can now access this advanced, non-invasive solution for migraine relief.
What is SAVI Dual sTMS Neuromodulation Treatment?
The SAVI Dual sTMS Neuromodulation treatment is an FDA-cleared therapy that employs Transcranial Magnetic Stimulation (TMS) to deliver a safe and effective approach for managing both acute migraines and migraine prevention. Uniquely, it serves as the first and sole portable, patient-controlled treatment, providing a medication-free option for those suffering from debilitating migraines.
How it Benefits Military and Veterans
The presence of the SAVI Dual sTMS Neuromodulation treatment on Recon Supply's contract means that prominent federal healthcare agencies, such as the Department of Veterans Affairs (VA), Department of Defense (DOD), and Indian Health Services (IHS), now have access to this innovative treatment at negotiated rates. This streamlining of procurement will ensure eligible patients receive timely access to modern migraine management solutions.
Expert Insights on the Partnership
According to Teresa Kazaros, Chief Operating Officer of eNeura Inc., there is palpable excitement surrounding this new development. She emphasized that this partnership aligns with their mission to ensure that those who serve the nation are equipped with the best possible treatment options for their migraine conditions. This sentiment resonates deeply, especially considering the number of individuals affected by migraines.
Recon Supply's Role in Advancing Patient Care
Recon Supply, a reputable distributor of medical technologies, took a proactive step by partnering with eNeura to make their treatment available. CEO Steve Clark stated that by adding eNeura's innovative treatment to their offerings, they could enhance access to proven therapies, ultimately uplifting the quality of patient care.
This collaboration embodies the essence of federal agencies and partners working together to improve healthcare provisions for those impacted by chronic conditions like migraines.
Why This Program is Important
With a substantial percentage of Americans—including veterans and active-duty military personnel—experiencing migraines, the expansion of the SAVI Dual sTMS Neuromodulation treatment through federal channels is crucial. It reflects a dedicated effort to tackle a widespread, debilitating health challenge that affects daily lives.
In light of these developments, individuals seeking relief from migraines can feel hopeful as more avenues for effective treatment are becoming available. The introduction of innovative technologies like the SAVI Dual sTMS embodies the future of migraine treatment, showcasing a shift towards non-invasive, patient-centered care.
Company Overview
eNeura Inc. is committed to advancing migraine treatment through cutting-edge, non-invasive technologies. Their flagship product focuses on providing consistent relief for those who suffer from migraines, transforming the way individuals manage their symptoms.
Recon Supply stands out as a trusted medical technology distributor, specializing in solutions tailored to federal healthcare needs. As a Service-Disabled Veteran-Owned Small Business (SDVOSB), it is dedicated to enhancing patient care and supporting the veteran community through innovative medical technologies.
Frequently Asked Questions
What is the SAVI Dual sTMS Neuromodulation treatment?
The SAVI Dual sTMS Neuromodulation treatment is a portable, patient-controlled therapy designed to treat acute migraines and provide prevention through Transcranial Magnetic Stimulation.
Who can access this treatment now?
Veterans, active-duty military personnel, and federal healthcare beneficiaries are now able to access the SAVI treatment through Recon Supply's Federal Supply Schedule contract.
Why is this partnership significant?
This partnership means that critical healthcare agencies can acquire innovative migraine treatment at negotiated prices, improving access to advanced medical care.
Who is leading eNeura's efforts?
eNeura Inc. is led by Teresa Kazaros, who emphasizes the company's dedication to serving those who serve the nation, ensuring they have access to effective migraine treatments.
What expertise does Recon Supply bring?
Recon Supply specializes in providing high-quality medical technologies to federal agencies, demonstrating commitment through its role as a Service-Disabled Veteran-Owned Small Business.
